Form 4: Agenus Inc. Director Jennifer Buell Reports Stock Transaction
SEC Form 4 Filing
Director Jennifer Buell acquired 581 shares of Agenus Inc. common stock as part of her salary compensation plan and disposed of 19,738 shares.
Summary
- On May 2, 2025, Jennifer Buell, a director of Agenus Inc., acquired 581 shares of common stock at a price of $3.11 per share as part of her salary compensation.
- This acquisition was made in lieu of cash payment for a portion of her salary, as approved by the Agenus Inc. Compensation Committee.
- The shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested upon issuance.
- Buell also disposed of 19,738 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports a transaction. The stock compensation plan is a common practice, but the disposal of shares could be seen as slightly negative.
Positives
- The arrangement to pay a portion of the director's salary in stock aligns her interests with those of the shareholders.
- The immediate vesting of shares could serve as an incentive for the director.
Industry Context
This type of stock-based compensation is common in the biotech industry to conserve cash and align management interests with shareholders. Many companies, especially smaller biotechs, use stock options and grants as a significant part of their compensation packages.
Comparison to Industry Standards
- Stock-based compensation is a common practice among publicly traded companies, particularly in the biotechnology sector.
- Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also utilize stock options and restricted stock units as part of their executive compensation packages.
- The specific amount and vesting schedules can vary widely based on company size, performance, and individual roles.
Stakeholder Impact
- The stock acquisition as part of salary compensation could be viewed positively by shareholders as it aligns the director's interests with theirs.
- Employees may view the stock compensation plan as a positive aspect of the company's compensation strategy.
Key Dates
| Date | Description |
|---|---|
| 05/02/2025 | Date of stock acquisition and disposal. |
| 05/02/2025 | Pay period ending date for salary paid in stock. |
| 05/06/2025 | Date of report filing. |
Keywords
Agenus Inc., Jennifer Buell, stock acquisition, Form 4, director, salary compensation, equity incentive plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.